nav-left cat-right
cat-right

Trana Discovery and Southern Research Institute Fi...

Trana Discovery and Southern Research Institute Find Bioactive HIV Antiviral Compounds: NIAID contracts additional $700,000 to screen 300,000 more compounds for HIV inhibition PRNewswire – October 28, 2009 CARY, N.C. and BIRMINGHAM, Ala., Oct. 28 /PRNewswire-USNewswire/ — Trana Discovery, Inc., an infectious disease drug discovery technology company, and Southern Research Institute, a not-for-profit contract...

DiscoveryBioMed Awarded $300,000 NIH Grant for Cys...

BIRMINGHAM, Ala. – (Business Wire) DiscoveryBioMed, Inc. (DBM) today announced that it has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH). The $308,000 grant will be used to advance certain small molecule drug discovery programs designed to correct the genetic mutation most common to cystic fibrosis (CF). “SBIR funding is an essential part of...

Scripps Researchers Win $3.9M NIH Grant for Protei...

NEW YORK (GenomeWeb News) – A pair of researchers from the Scripps Research Institute have been awarded a five-year, $3.9 million grant from the National Institutes of Health to develop a protein ligand screening technology. The grant, awarded through NIH’s recently introduced Roadmap Transformative grant program, will be shared by the laboratories of Tom Kodadek, a professor of chemistry and cancer biology at...

ERGONEX Pharma receives Frost & Sullivan̵...

Appenzell, Switzerland, October 19, 2009 / b3c newswire / – ERGONEX Pharma received one of the prestigious ‘European Orphan Diseases Entrepreneurial Company Award’ on the occasion of Frost & Sullivan’s ‘2009 Excellence in Healthcare Awards Banquet,’ held in London on 8th October 2009. The highly competitive award was presented to ERGONEX Pharma in recognition of the...

Scripps Research scientists awarded $3.9 million g...

Bicoastal effort could help revolutionize the search for new therapies La Jolla, CA, and Jupiter, FL, October 5, 2009 –A pair of scientists from The Scripps Research Institute, one on each coast, has been awarded a five-year $3.9 million grant from the National Institutes of Health (NIH) to develop a new technology to accelerate the search for new protein ligands – compounds that bind to proteins and alter their...

BioLeap Wins GlaxoSmithKline Contract to Design No...

BioLeap and GSK have entered into an agreement whereby BioLeap will design novel lead compounds for "difficult" drug targets. The targets (not disclosed) are ones for which conventional approaches, like high throughput screening, have failed to yield a viable chemical starting point. Typically these are in areas of high unmet medical need. BioLeap will use its computational fragment-based drug design platform...
Page 3 of 912345...Last »